PPT-The Regulatory Discussion Group

SAPRAA Meeting 12092014 Bytes Conference Centre Midrand Henriette Vienings Membership 1 st meeting 28022014 Discussion of CAMs regulations Members of the Group comprise Regulatory amp . the Financial Services Bill. . 19 March 2012 . The Senate Room, Senate House, . University of London. Professor Kern Alexander, . Chair for Law and Finance . University of Zürich and . Senior Research Fellow, Centre for Financial Analysis and Policy. October 2015. Addressing Regulatory Headwinds. Agenda. 2. Addressing Regulatory Headwinds. Agenda. What Regulations Are Doing To Financial Institutions. 3. Addressing Regulatory Headwinds. Agenda. What Regulations Are Doing To Financial Institutions. Exploring the Reasons behind Poor Sector Specific Performance. CPRSouth. 6, Bangkok, Thailand. December, 2011. Faheem Husain. (. faheem.hussain. [at]gmail.com. ). This work was carried out with the aid of a grant from the International Development Research Centre, Canada and the Department for International Development, UK.. . GMP- A Regulatory Perspective. Regulatory Perspective in entering . Global . Pharma. Markets. Regulatory Perspective in entering . Global . Pharma. Markets. World wide market of . pharma. products:. Do’s & Don’ts of Group Discussion. Process of Group Discussion. Preparing for Group Discussion. Evaluation Criteria of Group Discussion. 1. 2. 3. 4. 5. 6. 7. Learning Objectives. What is a Group Discussion. . displays. Lack . of Technical Solutions to Bridge . Gap / Recommendations. 1. Impact CEC’s Regulatory Language. : . Displays. CEC’s second draft display regulatory proposal more stringent / problematic than first draft . Discussion by bent vale. 2017 Biennial . iadi. research. . conference . Views. and . conclusions. . are. . the. . discussants. ’ . and . cannot. be . attributed. to Norges Bank. Main content of the paper. September . 2. 5, 2017. Walter T. Geary Jr., M.D.. Assistant State Health Officer for Regulatory Affairs. . . . REGULATORY INSIGHT. Regulatory Oversight. Why is there regulation of healthcare in the first place?. Anne E. Loccisano, PhD, DABT. Exponent, . Inc. VP-Elect, SOT/RSESS. GSLC-RSESS Webinar. October 31, 2017. What do regulatory toxicologists do anyway?. Broadly, regulatory toxicologists and risk assessors provide science-based advice to. Jim Corkill . | Controller. Business and Financial Services Controller’s Office. Stewardship. Stewardship. The careful and responsible management of something entrusted to one’s care.. Fund Accounting. Access and Rational Use. Blood, Radiological and Pharmaceutical Services. Regulatory System Strengthening. Systems approach/ Across all technologies. Contemplate the specificities off specific technologies. Investigational New Drug Application (IND); Summary of regulations and guidelines . Introduction of . cGMP's. /principles of validation . Introduction to QA/QC principles . Good Laboratory Practice (GLP) compliance . - . Cecchetti. & . Schoenholtz. Topic. Status. Recommendation. Capital. Up 2x since crisis. (requirements. up 10x). Raise. (much?) further. Liquidity. 2 new rules: LCR & NSFR. Simplify to one. Risks and Trends. Tom . Drennan. Dinsmore & . Shohl. LLP . Partner . Commercial Litigation. Insurance Litigation (Including Bad Faith). Insurance Claim And Underwriting Analysis. Insurance Regulatory Issues.